Marie‐Clotilde Alves‐Guerra

Centre National de la Recherche Scientifique — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index4.4kcitations123works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(43), Adipose Tissue and Metabolism(41), Mitochondrial Function and Pathology(40), CAR-T cell therapy research(29), Developmental Biology and Gene Regulation(12)

Publications123 total

An <i>in vivo</i> CRISPR screen unveils top target genes to improve CAR-T cell efficacy in a solid tumor model
2025Open Access
The alternative NF-κB RelB subunit is a novel critical sensor of lipid metabolism to promote tumor development
2024Open Access
Supplementary Figure 8 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 9 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 7 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 1 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 2 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 10 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 6 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 7 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Data from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 5 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Table 2 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 6 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 5 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 4 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 8 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Table 1 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 3 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
Supplementary Figure 10 from Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Claire Pecqueur(21), Bruno Miroux(18), Daniel Ricquier(15), Frédéric Bouillaud(12), A. Mostyn(7), Michael Symonds(7), Carina Prip‐Buus(6), Renaud Dentin(6), Terence Stephenson(6), Anthony J. Capobianco(5), Véronique Lenoir(5), Tiphaine Sancerni(5), Elodie Couplan(4), Anne‐Marie Cassard(4), Giulia Bertolin(4), Agnès Burel(4), Roland Le Borgne(4), Claude Prigent(4), Marc Tramier(4), Pauline Estèves(4)